1. Home
  2. All press releases

Approval for phase II trial with IPH 1101 in HCV

Innate Pharma S.A. has received approval for its phase II trial with IPH 1101 in Type C viral hepatitis.

PR in english 67.98 KB
CP en français 47.03 KB